Marian Szczepanik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marian Szczepanik has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
Monika Majewska-Szczepanik
Department of Medical Physiology, Faculty of Health Sciences, Institute of Physiotherapy, Jagiellonian University Medical College, Poland
18 shared publicationsAnna Strzępa
Faculty of Health Sciences, Institute of Physiotherapy, Jagiellonian University Medical College, Poland
16 shared publicationsKatarzyna Marcińska
Faculty of Health Sciences, Institute of Physiotherapy, Jagiellonian University Medical College, Poland
11 shared publications- Aneta Kiecka
Faculty of Health Sciences, Institute of Physiotherapy, Chair of Biomedical Sciences, Jagiellonian University Medical College, Kraków, Poland
10 shared publications - Barbara Macura
Faculty of Health Sciences, Institute of Physiotherapy, Chair of Biomedical Sciences, Jagiellonian University Medical College, Kraków, Poland
7 shared publications Marian Szczepanik
Department of Medical Biology, Jagiellonian University College of Medicine, Krakow, Poland
6 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by Springer Nature in Nutrire
- Vol. 51 (1) , 59
Novel immunomodulatory factors in human milk: implications for infant immunity
- 28 April 2026
- Published by Springer Nature in Nutrire
- Vol. 51 (1) , 59
Open AccessNovel immunomodulatory factors in human milk: implications for infant immunity
- Open Access
- 4 November 2025
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (6) , 1514-1526
Dietary modulation of the gut microbiome as a supportive strategy in the treatment of amyotrophic lateral sclerosis – a narrative review
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease leading to permanent damage to the central and peripheral motor neurons. Currently, there is no effective treatment for ALS, and therapy focuses solely on slowing the progression of the disease. Recent studies show that gut microbiota plays an important role in the development of neurodegenerative diseases. Altered gut microbiota has also been found in ALS. These changes have prompted the search for alternative forms of ALS treatment, focusing on changing the microbial composition of the gut. It has been noted that diet, probiotics, prebiotics and vitamins can all influence the course of ALS. Another interesting issue is fecal microbiota transplantation, which is already used in the treatment of certain intestinal diseases and could potentially be useful in the treatment of ALS. This review summarizes current knowledge on the impact of gut microbiota on the neurodegenerative process in ALS, with particular emphasis on the role of diet and probiotics. It also discusses potential mechanisms and highlights future research directions in this emerging field.
- 4 November 2025
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (6) , 1514-1526
Open AccessDietary modulation of the gut microbiome as a supportive strategy in the treatment of amyotrophic lateral sclerosis – a narrative review
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease leading to permanent damage to the central and peripheral motor neurons. Currently, there is no effective treatment for ALS, and therapy focuses solely on slowing the progression of the disease. Recent studies show that gut microbiota plays an important role in the development of neurodegenerative diseases. Altered gut microbiota has also been found in ALS. These changes have prompted the search for alternative forms of ALS treatment, focusing on changing the microbial composition of the gut. It has been noted that diet, probiotics, prebiotics and vitamins can all influence the course of ALS. Another interesting issue is fecal microbiota transplantation, which is already used in the treatment of certain intestinal diseases and could potentially be useful in the treatment of ALS. This review summarizes current knowledge on the impact of gut microbiota on the neurodegenerative process in ALS, with particular emphasis on the role of diet and probiotics. It also discusses potential mechanisms and highlights future research directions in this emerging field.
- Open Access
- 24 October 2025
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (6) , 1468-1490
The role of microbiota modulation in preventing Alzheimer’s disease- a review
Alzheimer’s disease (AD) is the most common form of dementia, and its incidence is projected to triple worldwide over the next 25 years. The most prevalent form, late-onset Alzheimer’s disease (LOAD), develops in genetically predisposed individuals exposed to environmental risk factors. Hallmarks of AD include accumulation of amyloid-β (Aβ), neurofibrillary tangles (NFTs), neuroinflammation, and mitochondrial dysfunction, resulting in oxidative stress, impaired glucose metabolism, and cognitive decline. Such metabolic disruptions result in early cerebral glucose hypometabolism and other metabolic disruptions, including altered lipid and branched-chain amino acid profiles. Recent evidence suggests that gut microbiota alterations, although individually variable, are a consistent and influential factor in AD progression via inflammatory and metabolic pathways. This narrative review explores therapeutic interventions targeting the gut-brain axis, including fecal microbiota transplantation (FMT), probiotic and antibiotic treatments, and dietary strategies such as the ketogenic and Mediterranean diets, as well as nutritional compounds such as omega-3 fatty acids. The aim is to evaluate the latest findings in both preclinical and clinical studies to identify multi-targeted, microbiota-based approaches for the prevention and management of AD.
- 24 October 2025
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (6) , 1468-1490
Open AccessThe role of microbiota modulation in preventing Alzheimer’s disease- a review
Alzheimer’s disease (AD) is the most common form of dementia, and its incidence is projected to triple worldwide over the next 25 years. The most prevalent form, late-onset Alzheimer’s disease (LOAD), develops in genetically predisposed individuals exposed to environmental risk factors. Hallmarks of AD include accumulation of amyloid-β (Aβ), neurofibrillary tangles (NFTs), neuroinflammation, and mitochondrial dysfunction, resulting in oxidative stress, impaired glucose metabolism, and cognitive decline. Such metabolic disruptions result in early cerebral glucose hypometabolism and other metabolic disruptions, including altered lipid and branched-chain amino acid profiles. Recent evidence suggests that gut microbiota alterations, although individually variable, are a consistent and influential factor in AD progression via inflammatory and metabolic pathways. This narrative review explores therapeutic interventions targeting the gut-brain axis, including fecal microbiota transplantation (FMT), probiotic and antibiotic treatments, and dietary strategies such as the ketogenic and Mediterranean diets, as well as nutritional compounds such as omega-3 fatty acids. The aim is to evaluate the latest findings in both preclinical and clinical studies to identify multi-targeted, microbiota-based approaches for the prevention and management of AD.
- 24 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e67578
Murine Model of Epicutaneously-Induced Immunomodulation
The skin, as the largest organ in the human body interfacing with the external environment, plays crucial physiological roles, including (1) protecting the organism from xenobiotics and microorganisms, (2) facilitating thermoregulation, (3) maintaining water and electrolyte balance, (4) synthesizing vitamin D, and (5) participating in immunity. This paper highlights the skin's pivotal involvement in immunological mechanisms, showcasing its capacity to immunomodulate by suppressing or potentiating the immune response. Previous findings reveal that, in mice, epicutaneous (EC) immunization with an antigen, either alone or in conjunction with pathogen-associated molecular patterns (PAMPs), can suppress or potentiate immune responses, respectively. Specifically, it was observed that EC immunization with an antigen can suppress immune responses in various murine models of autoimmune diseases or allergic contact dermatitis. The results indicate that EC immunization with an antigen combined with PAMPs could serve as an effective strategy to boost immunity against pathogens or alleviate T helper type 2 lymphocyte (Th2)-dependent allergies. This protocol outlines a method for inducing skin suppression via the epicutaneous application of an antigen in a murine model of human allergic contact dermatitis (ACD)-contact hypersensitivity (CHS) mediated by Th1 cells. However, it can also be applied to various murine disorder models. The article presents EC-induced immunomodulation as an attractive murine model for needle-free immunotherapy across various disorders.
- 24 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e67578
Murine Model of Epicutaneously-Induced Immunomodulation
The skin, as the largest organ in the human body interfacing with the external environment, plays crucial physiological roles, including (1) protecting the organism from xenobiotics and microorganisms, (2) facilitating thermoregulation, (3) maintaining water and electrolyte balance, (4) synthesizing vitamin D, and (5) participating in immunity. This paper highlights the skin's pivotal involvement in immunological mechanisms, showcasing its capacity to immunomodulate by suppressing or potentiating the immune response. Previous findings reveal that, in mice, epicutaneous (EC) immunization with an antigen, either alone or in conjunction with pathogen-associated molecular patterns (PAMPs), can suppress or potentiate immune responses, respectively. Specifically, it was observed that EC immunization with an antigen can suppress immune responses in various murine models of autoimmune diseases or allergic contact dermatitis. The results indicate that EC immunization with an antigen combined with PAMPs could serve as an effective strategy to boost immunity against pathogens or alleviate T helper type 2 lymphocyte (Th2)-dependent allergies. This protocol outlines a method for inducing skin suppression via the epicutaneous application of an antigen in a murine model of human allergic contact dermatitis (ACD)-contact hypersensitivity (CHS) mediated by Th1 cells. However, it can also be applied to various murine disorder models. The article presents EC-induced immunomodulation as an attractive murine model for needle-free immunotherapy across various disorders.
- 24 June 2025
- Published by MyJove Corporation
- No. 220,p. e67578
JoVE Video Dataset
The skin, as the largest organ in the human body interfacing with the external environment, plays crucial physiological roles, including (1) protecting the organism from xenobiotics and microorganisms, (2) facilitating thermoregulation, (3) maintaining water and electrolyte balance, (4) synthesizing vitamin D, and (5) participating in immunity. This paper highlights the skin's pivotal involvement in immunological mechanisms, showcasing its capacity to immunomodulate by suppressing or potentiating the immune response. Previous findings reveal that, in mice, epicutaneous (EC) immunization with an antigen, either alone or in conjunction with pathogen-associated molecular patterns (PAMPs), can suppress or potentiate immune responses, respectively. Specifically, it was observed that EC immunization with an antigen can suppress immune responses in various murine models of autoimmune diseases or allergic contact dermatitis. The results indicate that EC immunization with an antigen combined with PAMPs could serve as an effective strategy to boost immunity against pathogens or alleviate T helper type 2 lymphocyte (Th2)-dependent allergies. This protocol outlines a method for inducing skin suppression via the epicutaneous application of an antigen in a murine model of human allergic contact dermatitis (ACD)-contact hypersensitivity (CHS) mediated by Th1 cells. However, it can also be applied to various murine disorder models. The article presents EC-induced immunomodulation as an attractive murine model for needle-free immunotherapy across various disorders.
- 24 June 2025
- Published by MyJove Corporation
- No. 220,p. e67578
JoVE Video Dataset
The skin, as the largest organ in the human body interfacing with the external environment, plays crucial physiological roles, including (1) protecting the organism from xenobiotics and microorganisms, (2) facilitating thermoregulation, (3) maintaining water and electrolyte balance, (4) synthesizing vitamin D, and (5) participating in immunity. This paper highlights the skin's pivotal involvement in immunological mechanisms, showcasing its capacity to immunomodulate by suppressing or potentiating the immune response. Previous findings reveal that, in mice, epicutaneous (EC) immunization with an antigen, either alone or in conjunction with pathogen-associated molecular patterns (PAMPs), can suppress or potentiate immune responses, respectively. Specifically, it was observed that EC immunization with an antigen can suppress immune responses in various murine models of autoimmune diseases or allergic contact dermatitis. The results indicate that EC immunization with an antigen combined with PAMPs could serve as an effective strategy to boost immunity against pathogens or alleviate T helper type 2 lymphocyte (Th2)-dependent allergies. This protocol outlines a method for inducing skin suppression via the epicutaneous application of an antigen in a murine model of human allergic contact dermatitis (ACD)-contact hypersensitivity (CHS) mediated by Th1 cells. However, it can also be applied to various murine disorder models. The article presents EC-induced immunomodulation as an attractive murine model for needle-free immunotherapy across various disorders.
- Top Cited PapersOpen Access
- 28 September 2024
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-15
Intestinal permeability disturbances: causes, diseases and therapy
Nowadays, a pathological increase in the permeability of the intestinal barrier (the so-called leaky gut) is increasingly being diagnosed. This condition can be caused by various factors, mainly from the external environment. Damage to the intestinal barrier entails a number of adverse phenomena: dysbiosis, translocation of microorganisms deep into the intestinal tissue, immune response, development of chronic inflammation. These phenomena can ultimately lead to a vicious cycle that promotes the development of inflammation and further damage to the barrier. Activated immune cells in mucosal tissues with broken barriers can migrate to other organs and negatively affect their functioning. Damaged intestinal barrier can facilitate the development of local diseases such as irritable bowel disease, inflammatory bowel disease or celiac disease, but also the development of systemic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, hepatitis, and lupus erythematosus, neurodegenerative or psychiatric conditions, or metabolic diseases such as diabetes or obesity. However, it must be emphasized that the causal links between a leaky gut barrier and the onset of certain diseases often remain unclear and require in-depth research. In light of recent research, it becomes crucial to prevent damage to the intestinal barrier, as well as to develop therapies for the barrier when it is damaged. This paper presents the current state of knowledge on the causes, health consequences and attempts to treat excessive permeability of the intestinal barrier.
- 28 September 2024
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-15
Top Cited PapersOpen AccessIntestinal permeability disturbances: causes, diseases and therapy
Nowadays, a pathological increase in the permeability of the intestinal barrier (the so-called leaky gut) is increasingly being diagnosed. This condition can be caused by various factors, mainly from the external environment. Damage to the intestinal barrier entails a number of adverse phenomena: dysbiosis, translocation of microorganisms deep into the intestinal tissue, immune response, development of chronic inflammation. These phenomena can ultimately lead to a vicious cycle that promotes the development of inflammation and further damage to the barrier. Activated immune cells in mucosal tissues with broken barriers can migrate to other organs and negatively affect their functioning. Damaged intestinal barrier can facilitate the development of local diseases such as irritable bowel disease, inflammatory bowel disease or celiac disease, but also the development of systemic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, hepatitis, and lupus erythematosus, neurodegenerative or psychiatric conditions, or metabolic diseases such as diabetes or obesity. However, it must be emphasized that the causal links between a leaky gut barrier and the onset of certain diseases often remain unclear and require in-depth research. In light of recent research, it becomes crucial to prevent damage to the intestinal barrier, as well as to develop therapies for the barrier when it is damaged. This paper presents the current state of knowledge on the causes, health consequences and attempts to treat excessive permeability of the intestinal barrier.
- Open Access
- 25 August 2024
- Published by Polish Society of Microbiologists in Polish Journal of Microbiology
- Vol. 73 (3) , 265-273
The Presence of Lactobacillus spp. and its Effect on the Occurrence of Other Microorganisms in the Reproductive Tract of Polish Women
Disorders of the vaginal microbiota can lead to many complications and affect fertility. This study evaluates the role of Lactobacillus in the vagina and its impact on the incidence of colonization by pathogenic microorganisms, analyzing the results of 1,039 women of reproductive age (18–49 years) who underwent a microbiological examination of the reproductive tract in 2020. Samples were examined by microscopy, culture, and NAAT. As the number of Lactobacillus increases, the chance of developing symptoms decreases. In fact, it has been shown that the higher the number of Lactobacillus spp. the less frequently Gardnerella vaginalis and Streptococcus group B are observed. As the concentration of Lactobacillus spp. increases by one category, the risk of G. vaginalis after adjustment to age and pH decreases by 80% ( p < 0.001). Similarly, the correlation between Lactobacillus spp . and vaginal pH was shown. After adjustment to age, the odds of prevalence pH > 4.5 for people with Lactobacillus category higher 1 is 76% lower.
- 25 August 2024
- Published by Polish Society of Microbiologists in Polish Journal of Microbiology
- Vol. 73 (3) , 265-273
Open AccessThe Presence of Lactobacillus spp. and its Effect on the Occurrence of Other Microorganisms in the Reproductive Tract of Polish Women
Disorders of the vaginal microbiota can lead to many complications and affect fertility. This study evaluates the role of Lactobacillus in the vagina and its impact on the incidence of colonization by pathogenic microorganisms, analyzing the results of 1,039 women of reproductive age (18–49 years) who underwent a microbiological examination of the reproductive tract in 2020. Samples were examined by microscopy, culture, and NAAT. As the number of Lactobacillus increases, the chance of developing symptoms decreases. In fact, it has been shown that the higher the number of Lactobacillus spp. the less frequently Gardnerella vaginalis and Streptococcus group B are observed. As the concentration of Lactobacillus spp. increases by one category, the risk of G. vaginalis after adjustment to age and pH decreases by 80% ( p < 0.001). Similarly, the correlation between Lactobacillus spp . and vaginal pH was shown. After adjustment to age, the odds of prevalence pH > 4.5 for people with Lactobacillus category higher 1 is 76% lower.
- Open Access
- 23 August 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1390025
Proton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis suppressing contact hypersensitivity reaction in mice
Proton pump inhibitors (PPIs), such as omeprazole, are the most commonly prescribed drugs. Treatment with PPIs alters gut microbiota composition and reduces the production of reactive oxygen (ROS) and proinflammatory IL-1β, IL-6, and TNF-α cytokines. Here, using the T cell-dependent contact hypersensitivity (CHS) response, an animal model of allergic contact dermatitis (ACD) that affects up to 30% of the population, we demonstrated that a two-week omeprazole treatment suppresses the development of CHS. Omeprazole treatment before CHS induction, reduced inflammatory response in ears measured by ear swelling, ear biopsy weight, MPO activity, and proinflammatory cytokine production. These changes were associated with reduced frequency of TCRαβ+ CD4+ IL-17A+ and TCRαβ+ CD8+ IL-17A+ T cells and increased frequency of TCRαβ+ CD4+ CD25+ FoxP3+ Treg, and TCRαβ+ CD4+ IL-10+ Tr1 cells in peripheral lymphoid organs. Omeprazole treatment decreased the production of ROS, TNF-α, and IL-6, which supported Th17 cell induction, and increased the frequency of Clostridium cluster XIVab and Lactobacillus, implicated in Treg cell induction. The fecal microbiota transplantation (FMT) experiment confirmed the role of omeprazole-induced changes in gut microbiota profile in CHS suppression. Our data suggests that omeprazole ameliorates inflammatory response mediated by T-cells.
- 23 August 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1390025
Open AccessProton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis suppressing contact hypersensitivity reaction in mice
Proton pump inhibitors (PPIs), such as omeprazole, are the most commonly prescribed drugs. Treatment with PPIs alters gut microbiota composition and reduces the production of reactive oxygen (ROS) and proinflammatory IL-1β, IL-6, and TNF-α cytokines. Here, using the T cell-dependent contact hypersensitivity (CHS) response, an animal model of allergic contact dermatitis (ACD) that affects up to 30% of the population, we demonstrated that a two-week omeprazole treatment suppresses the development of CHS. Omeprazole treatment before CHS induction, reduced inflammatory response in ears measured by ear swelling, ear biopsy weight, MPO activity, and proinflammatory cytokine production. These changes were associated with reduced frequency of TCRαβ+ CD4+ IL-17A+ and TCRαβ+ CD8+ IL-17A+ T cells and increased frequency of TCRαβ+ CD4+ CD25+ FoxP3+ Treg, and TCRαβ+ CD4+ IL-10+ Tr1 cells in peripheral lymphoid organs. Omeprazole treatment decreased the production of ROS, TNF-α, and IL-6, which supported Th17 cell induction, and increased the frequency of Clostridium cluster XIVab and Lactobacillus, implicated in Treg cell induction. The fecal microbiota transplantation (FMT) experiment confirmed the role of omeprazole-induced changes in gut microbiota profile in CHS suppression. Our data suggests that omeprazole ameliorates inflammatory response mediated by T-cells.
- Open Access
- 28 June 2024
- Published by Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego in Sztuka Leczenia
- Vol. 39 (1) , 89-100
Wielokierunkowy wpływ wysiłku fizycznego na układ immunologiczny u sportowców wyczynowych
The extreme physical effort and psychological stress are everyday challenges faced by athletes. The regular training results in adaptation to increasing physical effort. It contributes to changes in various organs and metabolic processes. Intense physical training has been shown to affect numerous body systems including the immune system. The aim of this paper is to present the influence of extreme physical activity on various aspects of immune response. The changes in the immune system of athletes include not only those related to blood leukocytes, but those in connection to respiratory and gut associated lymphoid tissue as well. Moreover, the immune cells play an important role in muscle regeneration after sustaining training injury. The mmunology of physicial activity – mainly extreme physical activity – is a new, not fully recognized yet field of research. The understanding of these interactions facilitates a proper training planning for different groups of athletes.
- 28 June 2024
- Published by Uniwersytet Jagiellonski - Wydawnictwo Uniwersytetu Jagiellonskiego in Sztuka Leczenia
- Vol. 39 (1) , 89-100
Open AccessWielokierunkowy wpływ wysiłku fizycznego na układ immunologiczny u sportowców wyczynowych
The extreme physical effort and psychological stress are everyday challenges faced by athletes. The regular training results in adaptation to increasing physical effort. It contributes to changes in various organs and metabolic processes. Intense physical training has been shown to affect numerous body systems including the immune system. The aim of this paper is to present the influence of extreme physical activity on various aspects of immune response. The changes in the immune system of athletes include not only those related to blood leukocytes, but those in connection to respiratory and gut associated lymphoid tissue as well. Moreover, the immune cells play an important role in muscle regeneration after sustaining training injury. The mmunology of physicial activity – mainly extreme physical activity – is a new, not fully recognized yet field of research. The understanding of these interactions facilitates a proper training planning for different groups of athletes.
- 19 March 2024
- Published by Springer Nature in Pharmacological Reports
- Vol. 76 (2) , 251-262
Migraine and the microbiota. Can probiotics be beneficial in its prevention? - a narrative review
Migraine is a recurrent disease of the central nervous system that affects an increasing number of people worldwide causing a continuous increase in the costs of treatment. The mechanisms underlying migraine are still unclear but recent reports show that people with migraine may have an altered composition of the intestinal microbiota. It is well established that the gut-brain axis is involved in many neurological diseases, and probiotic supplementation may be an interesting treatment option for these conditions. This review collects data on the gastrointestinal and oral microbiota in people suffering from migraine and the use of probiotics as a novel therapeutic approach in its treatment.
- 19 March 2024
- Published by Springer Nature in Pharmacological Reports
- Vol. 76 (2) , 251-262
Migraine and the microbiota. Can probiotics be beneficial in its prevention? - a narrative review
Migraine is a recurrent disease of the central nervous system that affects an increasing number of people worldwide causing a continuous increase in the costs of treatment. The mechanisms underlying migraine are still unclear but recent reports show that people with migraine may have an altered composition of the intestinal microbiota. It is well established that the gut-brain axis is involved in many neurological diseases, and probiotic supplementation may be an interesting treatment option for these conditions. This review collects data on the gastrointestinal and oral microbiota in people suffering from migraine and the use of probiotics as a novel therapeutic approach in its treatment.